Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Comparison of PETINIA and LC-MS/MS for determining plasma mycophenolic acid concentrations in Japanese lung transplant recipients.

Kikuchi M, Tanaka M, Takasaki S, Takahashi A, Akiba M, Matsuda Y, Noda M, Hisamichi K, Yamaguchi H, Okada Y, Mano N.

J Pharm Health Care Sci. 2018 Apr 2;4:7. doi: 10.1186/s40780-018-0101-7. eCollection 2018.

2.

Monitoring Serum Levels of Sorafenib and Its N-Oxide Is Essential for Long-Term Sorafenib Treatment of Patients with Hepatocellular Carcinoma.

Shimada M, Okawa H, Kondo Y, Maejima T, Kataoka Y, Hisamichi K, Maekawa M, Matsuura M, Jin Y, Mori M, Suzuki H, Shimosegawa T, Mano N.

Tohoku J Exp Med. 2015 Nov;237(3):173-82. doi: 10.1620/tjem.237.173.

3.

Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis.

Murata Y, Song M, Kikuchi H, Hisamichi K, Xu XL, Greenspan A, Kato M, Chiou CF, Kato T, Guzzo C, Thurmond RL, Ohtsuki M, Furue M.

J Dermatol. 2015 Feb;42(2):129-39. doi: 10.1111/1346-8138.12726. Epub 2014 Dec 9.

PMID:
25491792
4.

A quantitative HPLC-UV method for determination of serum sorafenib and sorafenib N-oxide and its application in hepatocarcinoma patients.

Shimada M, Okawa H, Maejima T, Yanagi T, Hisamichi K, Matsuura M, Akasaka K, Tsuchiya M, Kondo Y, Shimosegawa T, Mori M, Maekawa M, Suzuki H, Mano N.

Tohoku J Exp Med. 2014 Jun;233(2):103-12.

5.

Cutaneous and systemic plasmacytosis vs. cutaneous plasmacytic castleman disease: review and speculations about pathogenesis.

Haque M, Hou JS, Hisamichi K, Tamada K, Cusack CA, Abdelmalek M, Brown RE, Vonderheid EC.

Clin Lymphoma Myeloma Leuk. 2011 Dec;11(6):453-61. doi: 10.1016/j.clml.2011.07.004. Epub 2011 Sep 21. Review.

PMID:
21940235
6.

Preventive and therapeutic potential of placental extract in contact hypersensitivity.

Kim YS, Park JJ, Sakoda Y, Zhao Y, Hisamichi K, Kaku T, Tamada K.

Int Immunopharmacol. 2010 Oct;10(10):1177-84. doi: 10.1016/j.intimp.2010.06.024. Epub 2010 Jul 7.

7.

Efficacy of oral minocycline and hyperthermic treatment in a case of atypical mycobacterial skin infection by Mycobacterium marinum.

Hisamichi K, Hiruma M, Yamazaki M, Matsushita A, Ogawa H.

J Dermatol. 2002 Dec;29(12):810-1.

PMID:
12532049
8.

Primary cutaneous nocardiosis with multiple, subcutaneous abscesses in a patient with sarcoidosis.

Hashimoto Y, Hiruma M, Hisamichi K, Mitsuishi K, Mikami Y, Ogawa H.

J Dermatolog Treat. 2002 Dec;13(4):201-3.

PMID:
19753742
9.

Two Japanese cases of localized involutional lipoatrophy.

Hisamichi K, Suga Y, Hashimoto Y, Matsuba S, Mizoguchi M, Ogawa H.

Int J Dermatol. 2002 Mar;41(3):176-7.

PMID:
12010346
10.

The conformational study of chitin and chitosan oligomers in solution.

Sugiyama H, Hisamichi K, Sakai K, Usui T, Ishiyama JI, Kudo H, Ito H, Senda Y.

Bioorg Med Chem. 2001 Feb;9(2):211-6.

PMID:
11249112
11.

The conformation of alpha-(1-->4)-linked glucose oligomers from maltose to maltoheptaose and short-chain amylose in solution.

Sugiyama H, Nitta T, Horii M, Motohashi K, Sakai J, Usui T, Hisamichi K, Ishiyama JI.

Carbohydr Res. 2000 Apr 20;325(3):177-82.

PMID:
10795808
12.

A newly recognized acetylated metabolite of arbekacin in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.

Fujimura S, Tokue Y, Takahashi H, Nukiwa T, Hisamichi K, Mikami T, Watanabe A.

J Antimicrob Chemother. 1998 Apr;41(4):495-7. No abstract available.

PMID:
9598784
13.

NMR study of the galactomannans of Trichophyton mentagrophytes and Trichophyton rubrum.

Ikuta K, Shibata N, Blake JS, Dahl MV, Nelson RD, Hisamichi K, Kobayashi H, Suzuki S, Okawa Y.

Biochem J. 1997 Apr 1;323 ( Pt 1):297-305.

14.

Existence of novel branched side chains containing beta-1,2 and alpha-1,6 linkages corresponding to antigenic factor 9 in the mannan of Candida guilliermondii.

Shibata N, Akagi R, Hosoya T, Kawahara K, Suzuki A, Ikuta K, Kobayashi H, Hisamichi K, Okawa Y, Suzuki S.

J Biol Chem. 1996 Apr 19;271(16):9259-66.

15.
16.

Expression of alpha-1,3 linkage-containing oligomannosyl residues in a cell-wall mannan of Candida tropicalis grown in yeast extract-Sabouraud liquid medium under acidic conditions.

Kobayashi H, Shibata N, Suzuki A, Takahashi S, Suzuki M, Matsuda K, Hisamichi K, Suzuki S.

FEBS Lett. 1994 Mar 28;342(1):19-22.

18.

Mild acetolysis and NMR studies of the D-mannan of Saccharomyces cerevisiae X2180-1A wild-type strain.

Kobayashi H, Shibata N, Watanabe M, Komido M, Hashimoto N, Hisamichi K, Suzuki S.

Carbohydr Res. 1992 Jul 2;231:317-23. No abstract available.

PMID:
1394323
19.
20.

Epimerization of reducing terminal groups of (1----2)-linked D-gluco- and D-manno-disaccharides in aqueous sodium hydroxide.

Kobayashi H, Shibata N, Konno S, Hisamichi K, Suzuki S.

Carbohydr Res. 1992 May 22;229(2):369-75. No abstract available.

PMID:
1394294
21.

Structural study on a phosphorylated mannotetraose obtained from the phosphomannan of Candida albicans NIH B-792 strain by acetolysis.

Shibata N, Kobayashi H, Takahashi S, Okawa Y, Hisamichi K, Suzuki S, Suzuki S.

Arch Biochem Biophys. 1991 Nov 1;290(2):535-42.

PMID:
1929420
22.

[Studies on pyridinol derivatives. X. Synthesis and pharmacological activity of 4-acyl-3,4-dihydro-2H-pyrido[3,2-b]-1,4-oxazine derivatives].

Takeda H, Hisamichi K.

Yakugaku Zasshi. 1983 Dec;103(12):1247-56. Japanese. No abstract available.

PMID:
6677715
23.

[Pyridinol derivatives. (9) Synthesis and pharmacological activity of 4-phenylalkyl-3,4-dihydro-2H-pyrido[3,2-b]-1,4-oxazine derivatives].

Takeda H, Muroga S, Fujita H, Hisamichi K, Suzuki S.

Yakugaku Zasshi. 1983 Aug;103(8):857-66. Japanese. No abstract available.

PMID:
6663464
24.

[Pyridinol derivatives. (8) Synthesis and pharmacological activity of 4-phenylalkyl-2H-pyrido[3,2-b]-1,4-oxazin-3-one derivatives].

Takeda H, Fujita H, Muroga S, Suzuki S, Hisamichi K.

Yakugaku Zasshi. 1983 Aug;103(8):849-56. Japanese. No abstract available.

PMID:
6663463
25.

[Pyridinol derivatives. (7) Synthesis and pharmacological activity of 4-(2-dialkylamino-1-phenylethyl)-3,4-dihydro-2H-pyrido[3,2-b]-1,4-oxazine derivatives].

Takeda H, Muroga S, Fujita H, Hisamichi K, Suzuki S.

Yakugaku Zasshi. 1983 Aug;103(8):835-48. Japanese. No abstract available.

PMID:
6663462
26.

[Pyridinol derivatives. (6) Synthesis and pharmacological activity of 4-(2-dialkylamino-1-phenylethyl)-2H-pyrido[3,2-b]-1,4-oxazin-3-one derivatives].

Takeda H, Fujita H, Muroga S, Suzuki S, Hisamichi K.

Yakugaku Zasshi. 1983 Aug;103(8):825-34. Japanese. No abstract available.

PMID:
6663461
27.

[Pyridinol derivatives (4). Synthesis and pharmacological actions of 3,4-dihydro-2H-pyrido[3,2-b]-1,4-oxazine derivatives. (1)].

Takeda H, Hisamichi K, Fujita H, Muroga S, Suzuki S.

Yakugaku Zasshi. 1983 May;103(5):497-507. Japanese. No abstract available.

PMID:
6644543
28.

[Studies on pyridinol derivatives. III. Synthesis and pharmacological activity of 2H-pyrido [3,2-b]-1,4-oxazin-3-one derivatives].

Takeda H, Hisamichi K.

Yakugaku Zasshi. 1983 Feb;103(2):153-64. Japanese. No abstract available.

PMID:
6864455
29.

[Studies on pyridinol derivatives. II. Synthesis and pharmacological activity of 2H-pyrido[3,2-b]-1,4-oxazin-3-one derivatives].

Takeda H, Suzuki S, Hisamichi K.

Yakugaku Zasshi. 1983 Feb;103(2):143-52. Japanese. No abstract available.

PMID:
6864454
30.

[Effect of Alfence (metal splint) on deformity of the sternum after open heart surgery in children].

Okamura H, Katakura K, Hisamichi K, Sato T, Noto T.

Kyobu Geka. 1967 Jun;20(6):410-6. Japanese. No abstract available.

PMID:
5624956

Supplemental Content

Loading ...
Support Center